Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Cerebral Cortex (New York, N.Y. : 1991)|September 13, 2024
Receptive-field nonlinearities in primary auditory cortex: a comparative perspectiveNatsumi Y Homma, Jermyn Z See, Craig A Atencio, et al.
Human Brain Mapping|December 25, 2024
Therapeutic DBS for OCD Suppresses the Default Mode NetworkNatalya Slepneva, Genevieve Basich-Pease, Lee Reid, et al.
Annals of Neurology|January 29, 2015
Differential effects of deep brain stimulation target on motor subtypes in Parkinson's diseaseMaya Katz, Marta San Luciano, Kimberly Carlson, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Therapeutic DBS for OCD Suppresses the Default Mode NetworkNatalya Slepneva, Genevieve Basich-Pease, Lee Reid, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2020
Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJohn G Nutt, Carolin Curtze, Amie Hiller, et al.
Stereotactic and Functional Neurosurgery|April 16, 2011
Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brainR Mark Richardson, Adrian P Kells, Alastair J Martin, et al.
The Laryngoscope|May 10, 2019
Cortical-Basal Ganglia-Cerebellar Networks in Unilateral Vocal Fold Paralysis: A Pilot StudyPhilip L Perez, Kristine L Cueva, Clark A Rosen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 24, 2011
Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's diseaseR Mark Richardson, Adrian P Kells, Kathryn H Rosenbluth, et al.
Neurosurgery|September 7, 2022
Targeting Accuracy and Clinical Outcomes of Awake versus Asleep Interventional Magnetic Resonance Imaging-Guided Deep Brain Stimulation for Parkinson's Disease: The University of California, San Francisco ExperienceAnthony T Lee, Kasey J Han, Noah Nichols, et al.
Neurology|October 15, 2021
Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 TrialChadwick W Christine, R Mark Richardson, Amber D Van Laar, et al.
Pageof 17